3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid, 97%, 500mg

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 50mg

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic acid, 98.0%, 10g

Methyl 2-(4-methoxyphenyl)acetate, 98.0%, 5g

Thalidomide-O-C4-COOH, 500mg

3,4-DIHYDRO-6-[[4-[[[3-(METHYLSULFONYL)PHENYL]METHYL]AMINO]-5-(TRIFLUOROMETHYL)-PYRIMIDIN-2-YL]AMINO]-2(1H)-QUINOLINONE, 98%, 25mg

2-(1-((Benzyloxy)carbonyl)azetidin-3-yl)acetic acid, 95.0%, 25g

2-(4-Methoxy-phenyl)-3-piperazin-1-ylmethyl-imidazo[1,2-a]pyridine oxalic acid salt, 1g

(3-BROMOISOXAZOL-5-YL)METHYLAMINE HCL, 95%, 500mg

4-BROMO-7-NITRO-1H-INDAZOLE, 95%, 5g

4-(tert-Butoxy)phenol, 98.0%, 10g

1-(BROMOMETHYL)-3-ISOPROPYLBENZENE, 95.0%, 5g

Rotilabo®-Filtertiegel aus glasiertem, Porzellan, Volumen 25 ml, Porengr. 8 µm, 2 Stück